220 related articles for article (PubMed ID: 19468265)
1. Myeloid disease.
Tallman MS
Curr Opin Hematol; 2009 Mar; 16(2):63. PubMed ID: 19468265
[No Abstract] [Full Text] [Related]
2. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
3. Second biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Bohlius J; Trelle S; Engert A
J Natl Cancer Inst; 2005 Apr; 97(7):E1. PubMed ID: 15812063
[No Abstract] [Full Text] [Related]
4. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
Niemann CU; Kjeldsen L; Ralfkiaer E; Jensen MK; Borregaard N
Leukemia; 2007 Dec; 21(12):2406-10. PubMed ID: 17928883
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia.
Rubnitz JE; Gibson B; Smith FO
Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute myeloid leukemia--focusing on the data from JALSG studies].
Miyawaki S
Rinsho Ketsueki; 2008 Oct; 49(10):1386-93. PubMed ID: 18833923
[No Abstract] [Full Text] [Related]
7. Liquid tumors in the elderly.
Mato A; Feldman T; Richter J; Siegel DS; Goy A
Clin Geriatr Med; 2012 Feb; 28(1):115-52. PubMed ID: 22326039
[No Abstract] [Full Text] [Related]
8. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
[No Abstract] [Full Text] [Related]
9. [Diagnostics and therapy of acute myeloid leukemia].
Bornhäuser M; Ehninger G
Dtsch Med Wochenschr; 2009 Sep; 134(39):1935-41. PubMed ID: 19760554
[No Abstract] [Full Text] [Related]
10. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
Lu H; Lu SF; Shen WY; Hong M; Zhang JF; Wang LX; Yang H; Li JY
Leuk Res; 2008 Nov; 32(11):1776-9. PubMed ID: 18501425
[No Abstract] [Full Text] [Related]
11. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.
Westin GF; Dias AL; Go RS
Curr Hematol Malig Rep; 2016 Aug; 11(4):271-9. PubMed ID: 27177742
[TBL] [Abstract][Full Text] [Related]
12. Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.
Focosi D; Caracciolo F; Galimberti S; Papineschi F; Petrini M
Ann Hematol; 2008 Mar; 87(3):233-5. PubMed ID: 17846771
[No Abstract] [Full Text] [Related]
13. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
Brach MA; Henschler R; Mertelsmann R; Herrmann F
Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
[No Abstract] [Full Text] [Related]
14. [Acute leukemia. First part--acute myeloblastic leukemia:diagnosis, clinical course].
Boissel N; Dombret H
Rev Prat; 2006 Jan; 56(1):71-8. PubMed ID: 16548252
[No Abstract] [Full Text] [Related]
15. Myeloid (granulocytic) sarcoma of epididymis as rare manifestation of recurrent acute myelogenous leukemia.
Sarvis JA; Auge BK
Urology; 2009 May; 73(5):1163.e1-3. PubMed ID: 18602141
[TBL] [Abstract][Full Text] [Related]
16. Acute leukaemia presenting as vulvar ulcers in an adolescent girl.
Gupta S; Maheshwari A; Gujral S; Kelkar R; Parikh P; Tongaonkar H
Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):536-7. PubMed ID: 16401227
[No Abstract] [Full Text] [Related]
17. Curing acute myelogenous leukemia: still a major challenge.
Smith BD; Karp JE
Leuk Res; 2005 Jun; 29(6):607-8. PubMed ID: 15863198
[No Abstract] [Full Text] [Related]
18. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
19. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
Tefferi A
Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
[No Abstract] [Full Text] [Related]
20. Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms.
Herlihy N; Harrison CN; McLornan DP
Haematologica; 2019 Apr; 104(4):639-641. PubMed ID: 30930333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
